Santalis Pharmaceuticals   Report issue

For profit Phase 2
Founded: San Antonio TX United States (2010)
Status: Acquired by ViroXis Corporation (2015) → now TFS Trial Form Support (2015)

Organization Overview

First Clinical Trial
2015
NCT02399228
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Santalis Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 2 Trials (3)

east indian sandalwood oil (1 trial)

san007 (2 trials)

san021 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Mucositis (Phase 2)

Psoriasis (Phase 2)

Stomatitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 3